Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients

BACKGROUND: Dysbiosis of the gut microbiota can lead to impaired therapeutic effect of immune checkpoint inhibitors (ICIs). This study aimed to investigate the use of probiotics on the clinical outcomes of cancer patients receiving ICIs therapy. METHOD: PubMed, EMBASE, and the Cochrane Library datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Luying, Wu, Chunlan, Wu, Qin, Luo, Shuimei, Liu, Junjin, Xie, Xianhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883533/
https://www.ncbi.nlm.nih.gov/pubmed/35770869
http://dx.doi.org/10.1002/cam4.4994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883533/
https://www.ncbi.nlm.nih.gov/pubmed/35770869
http://dx.doi.org/10.1002/cam4.4994

Ejemplares similares